PRESS RELEASE AB SCIENCE PATENT FOR MASITINIB IN THE TREATMENT OF SICKLE CELL DISEASE FORMALLY GRANTED IN THE UNITED STATES WITH A PROTECTION UNTIL 2040 THIS DECISION STRENGTHENS MASITINIB’S INTELLECTUAL PROPERTY PORTFOLIO WITH LONG-TERM PROTECTION FOR AN ADDITIONAL INDICATION WITH A HIGH UNMET MEDICAL NEED THE BIOMARKER PHASE 2 IN COOPERATION WITH AP-HP IS FULLY FUNDED Paris, December 22, 2025, 6pm CET AB Science SA (Euronext - FR0010557264 - AB) today announced that the United States Patent Office has fo ...

Strategic Actions to Align with Shareholders' Interests and Significant Cash Savings ExpectedGRAPEVINE, Texas, Dec. 22, 2025 (GLOBE NEWSWIRE) -- Solo Brands, Inc. (NYSE: SBDS) (“Solo Brands” or “the Company”) a leading portfolio of lifestyle brands (Solo Stove, Chubbies, Isle and Oru) that are redefining the outdoor and apparel industries, announced that it is conducting a series of transactions that will simplify its organizational structure, including the elimination of its umbrella partnership C corporat ...

SHENZHEN, China, Dec. 22, 2025 (GLOBE NEWSWIRE) -- MicroCloud Hologram Inc. (NASDAQ: HOLO), (“HOLO” or the "Company"), a technology service provider, launched a brand-new FPGA-based quantum computing simulation framework founded on a serial-parallel architecture. This framework adopts an innovative hardware-level data path design and, by redefining the execution mode of quantum gate operations, achieves a linear reduction in resource utilization. This framework not only demonstrates the inherent advantages ...

Regulated information Paris, December 22, 2025 DISCLOSURE FISCAL 2026/07 OF TRANSACTIONS ON TREASURY SHARES Period of: December 15 to December 19, 2025 Issuer: Pluxee N.V. Class of Securities: Ordinary shares (ISIN NL0015001W49) Aggregate presentation by day and by market. Issuer CodeTransaction dateISIN CodeDaily total volume (in number of shares)Daily weighted average price of shares acquiredPlatform213800RQNIQT48SEEO8515-Dec-25NL0015001W4929 61913,4896XPAR213800RQNIQT48SEEO8515-Dec-2 ...

Nanterre, December 22nd, 2025 Disclosure of transactions in on shares from December 15th to December 19th,2025 Within the framework of the authorization granted by the General Meeting of VINCI SA of April 17th, 2025, to trade in its shares and in accordance with the regulations relating to share buybacks, VINCI SA (LEI:213800WFQ334R8UXUG83) declares the purchases of treasury shares below (FR0000125486), carried out from December 15th to December 19th,2025: I - Aggregate presentation by day and by market ...

Schindellegi, Switzerland – 22 December 2025 Trifork Group AGCompany announcement no. 59/2025European Regulatory News Reporting of transactions made by persons discharging managerial responsibilities Pursuant to the Market Abuse Regulation Article 19, Trifork Group AG (Swiss company registration number CHE-474.101.854) (“Trifork”) hereby notifies receipt of information of the following transactions made by persons discharging managerial responsibilities in Trifork in connection with fixed salaries paid in s ...

Sword Group confirms the sale of its subsidiary Tipik to mci group, an internationally recognised player in the field of event and institutional communication. This divestment marks the end of Sword’s involvement in event-related activities, fully aligned with its strategy to refocus on its core businesses: digital transformation and high value-added services. mci group, a long-standing partner of Sword, is accelerating its growth and strengthening its service portfolio as well as its communication expertis ...

Aspo Plc ANNOUNCEMENT 22.12.2025 Aspo Plc: Share repurchase 22.12.2025 In the Helsinki Stock Exchange Trade date 22.12.2025 Bourse trade Buy Share ASPO Amount 3 000SharesAverage price/ share 6,5000EURTotal cost 19 500,00EUR Aspo Plc now holds ...

Long-term data published in JAMA Neurology further illustrate the effects of Biogen’s QALSODY on function, strength, and survival in SOD1-ALSOver 3 years, a subset of QALSODY-treated participants regained previously lost function and strength, something not previously reported in the natural history of SOD1-ALSBiogen is committed to advancing additional ALS research, including the ongoing QALSODY ATLAS study in pre-symptomatic SOD1-ALS and a robust discovery pipeline in ALS CAMBRIDGE, Mass., Dec. 22, 2025 ( ...

公司项目进展 - 公司股东Albright Metals Limited（前身为Bryah Resources Ltd）在新不伦瑞克省的Golden Pike金锑矿权地（由公司选择权持有）取得进展 [1] - Albright公司已完成其Vail Road高品位金矿藏的 infill 和 extensional 钻探计划 共获取约990米的定向HQ金刚石钻芯 来自15个钻孔 目标区域已按预期截获 样品已送实验室分析 结果预计于1月逐步收到 [2] - 钻机将移至Bond Road锑矿点 进行初步钻探勘探计划 目标区域土壤异常显著 且地表已发现高品位辉锑矿巨砾 钻场准备和通道清理已完成 勘探钻探计划于1月初开始 计划进行高达1,200米的金刚石岩心钻探 [3] 资源评估与开发重点 - Albright公司当前重点是推进Vail Road金矿藏（拥有NI 43-101 Foreign Resource Estimate）的开发 [4] - 从 infill 和 extensional 钻探获得的钻探结果和数据将被用于将 foreign resource estimate 升级为符合JORC标准的矿产资源量估算 [5] - 除了Vail Road高品位金矿藏的工作外 矿权地北半部分多个金和锑矿化目标正在被评估和优先排序 以备后续勘探 [5] 公司态度与背景信息 - 公司对Golden Pike矿权地的快速推进计划感到满意 并期待该矿权地潜力能迅速提升 [5] - 公司已发行流通股为56,347,436股 [8]